TP Therapeutics' Series C Round

TP Therapeutics raised a round of funding on May 23, 2017.

TP Therapeutics (TP) is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. TP Therapeutics is focused on the d…

Articles about TP Therapeutics' Series C Round: